Is it the primetime for endoglin (CD105) in the clinical setting? - Suppr | 超能文献

Is it the primetime for endoglin (CD105) in the clinical setting?

作者信息

Maio Michele, Altomonte Maresa, Fonsatti Ester

出版信息

Cardiovasc Res. 2006 Mar 1;69(4):781-3. doi: 10.1016/j.cardiores.2006.01.007. Epub 2006 Jan 31.

DOI:10.1016/j.cardiores.2006.01.007

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Is it the primetime for endoglin (CD105) in the clinical setting?

Cardiovasc Res. 2006 Mar 1;69(4):781-3. doi: 10.1016/j.cardiores.2006.01.007. Epub 2006 Jan 31.

2

Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.通过内胚层蛋白/CD105 靶向肿瘤血管：实体瘤中一种新的基于抗体的诊断和治疗策略。

Cardiovasc Res. 2010 Apr 1;86(1):12-9. doi: 10.1093/cvr/cvp332. Epub 2009 Oct 7.

3

Re: the risk of developing metastatic disease in colorectal cancer is related to CD105-positive vessel count, by Romani AA, Borghetti AF, Del Rio P, et al.

J Surg Oncol. 2006 May 1;93(6):435-6. doi: 10.1002/jso.20457.

4

The differences between the endothelial area marked with CD31 and CD105 in colorectal carcinomas by computer-assisted morphometrical analysis.通过计算机辅助形态计量分析，结直肠癌中CD31和CD105标记的内皮区域之间的差异。

Rom J Morphol Embryol. 2009;50(2):239-43.

5

[Endoglin (CD105)--a target for visualization and anti-angiogenic therapy for malignant tumors].[内皮糖蛋白（CD105）——恶性肿瘤可视化及抗血管生成治疗的靶点]

Vopr Onkol. 2015;61(6):898-907.

6

[Role of angiogenesis inhibitors in the treatment of colorectal cancer].[血管生成抑制剂在结直肠癌治疗中的作用]

Magy Onkol. 2007;51(2):139-44. Epub 2007 Jul 29.

7

Targeting of vasculature in cancer and other angiogenic diseases.针对癌症及其他血管生成性疾病中的脉管系统

Trends Immunol. 2001 Mar;22(3):129. doi: 10.1016/s1471-4906(00)01840-8.

8

Current role of bevacizumab in colorectal cancer.贝伐单抗在结直肠癌中的当前作用。

Clin Adv Hematol Oncol. 2009 Jun;7(6):375-6.

9

Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.内皮糖蛋白（CD105）：肿瘤相关血管生成血管上的一个强大治疗靶点。

Oncogene. 2003 Sep 29;22(42):6557-63. doi: 10.1038/sj.onc.1206813.

10

Effective anti-angiogenic therapy of established tumors in mice by naked anti-human endoglin (CD105) antibody: differences in growth rate and therapeutic response between tumors growing at different sites.裸抗人内皮糖蛋白（CD105）抗体对小鼠已形成肿瘤的有效抗血管生成治疗：不同部位生长肿瘤的生长速率和治疗反应差异

Int J Oncol. 2006 Nov;29(5):1087-94.

引用本文的文献

1

Mesenchymal-to-endothelial transition in Kaposi sarcoma: a histogenetic hypothesis based on a case series and literature review.卡波西肉瘤中的间充质到内皮细胞的转化：基于一系列病例和文献复习的组织发生假说。

PLoS One. 2013 Aug 6;8(8):e71530. doi: 10.1371/journal.pone.0071530. Print 2013.

2

Use of ribosome-inactivating proteins from Sambucus for the construction of immunotoxins and conjugates for cancer therapy.利用桑菊中的核糖体失活蛋白构建免疫毒素和用于癌症治疗的缀合物。

Toxins (Basel). 2011 May;3(5):420-41. doi: 10.3390/toxins3050420. Epub 2011 Apr 29.